ZME Science
No Result
View All Result
ZME Science
No Result
View All Result
ZME Science

Home → Health → Diseases

Anti-cancer virus shows promise

Mihai AndreibyMihai Andrei
August 31, 2011 - Updated on November 5, 2013
in Diseases, Health
A A
Share on FacebookShare on TwitterSubmit to Reddit

An engineered virus injected directly in the patient’s blood has shown some remarkable promise in targeting and destroying cancer cells, in what researchers have called a first.

Using viruses to attack cancer isn’t really a novel concept, but until now, they had to be injected directly into the tumour, which leads to several other complications. But this new breakthrough could really change therapies, as the virus attacked only the cancerous cells and leaved the healthy tissue untouched, even when injected directly into the blood.

For the purpose of this treatment, researchers modified the vaccinia virus, which is most famous for helping develop a smallpox vaccine. The virus, named JX-594, is dependent upon a chemical pathway, common in some cancers, in order to replicate. So far, it was injected in different doses in 23 patients, all of which had cancerous cells in multiple organs. Out of 8 who were given the highest dose, in 7, the virus replicated in tumours and started attacking the cancer cells, leaving the healthy areas alone.

Prof John Bell, lead researcher and from the University of Ottawa, said:

“We are very excited because this is the first time in medical history that a viral therapy has been shown to consistently and selectively replicate in cancer tissue after intravenous infusion in humans. “Intravenous delivery is crucial for cancer treatment because it allows us to target tumours throughout the body as opposed to just those that we can directly inject.”

The infection prevented further tumour growth in six patients; however, the virus didn’t cure the cancer. The patients were given only one dose of the virus as the trial was designed to test the safety of the virus.

Cancer Research UK’s Prof Nick Lemoine, also director of Barts Cancer Institute, said:

“Viruses that multiply in just tumour cells – avoiding healthy cells – are showing real promise as a new biological approach to target hard-to-treat cancers. This new study is important because it shows that a virus previously used safely to vaccinate against smallpox in millions of people can now be modified to reach cancers through the bloodstream – even after cancer has spread widely through the patient’s body. It is particularly encouraging that responses were seen even in tumours like mesothelioma, a cancer which can be particularly hard to treat.”

UPDATE: In 2013, a vaccine with 50% regression rate was tested on mice. Human clinical trials might begin shortly.

RelatedPosts

Extremely rare case of death from bat rabies in France
Lung cancer may be detected with a cheek swab
NYC mice are crawling with antibiotic-resistant bacteria and viruses
Deep lying bacteria found, reproduce only once in 10.000 years
Tags: cancervirus

ShareTweetShare
Mihai Andrei

Mihai Andrei

Dr. Andrei Mihai is a geophysicist and founder of ZME Science. He has a Ph.D. in geophysics and archaeology and has completed courses from prestigious universities (with programs ranging from climate and astronomy to chemistry and geology). He is passionate about making research more accessible to everyone and communicating news and features to a broad audience.

Related Posts

A unique eye accessory
Health

Miracle surgery: Doctors remove a hard-to-reach spinal tumor through the eye of a patient

byRupendra Brahambhatt
1 week ago
Health

This Futuristic Laser Blood Test May Be the Key to Beating Cancer Early

byTudor Tarita
4 weeks ago
Health

CT Scans Save Lives But Researchers Now Say They Could Also Be Behind 100,000 Future Cancer Cases

byTibi Puiu
1 month ago
Health

Scientists uncover how aspirin may help stop cancer from spreading

byAlexandra Gerea
2 months ago

Recent news

The Worm That Outsourced Locomotion to Its (Many) Butts

May 16, 2025

The unusual world of Roman Collegia — or how to start a company in Ancient Rome

May 16, 2025
Merton College, University of Oxford. Located in Oxford, Oxfordshire, England, UK. Original public domain image from Wikimedia Commons

For over 500 years, Oxford graduates pledged to hate Henry Symeonis. So, who is he?

May 16, 2025
  • About
  • Advertise
  • Editorial Policy
  • Privacy Policy and Terms of Use
  • How we review products
  • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Science News
  • Environment
  • Health
  • Space
  • Future
  • Features
    • Natural Sciences
    • Physics
      • Matter and Energy
      • Quantum Mechanics
      • Thermodynamics
    • Chemistry
      • Periodic Table
      • Applied Chemistry
      • Materials
      • Physical Chemistry
    • Biology
      • Anatomy
      • Biochemistry
      • Ecology
      • Genetics
      • Microbiology
      • Plants and Fungi
    • Geology and Paleontology
      • Planet Earth
      • Earth Dynamics
      • Rocks and Minerals
      • Volcanoes
      • Dinosaurs
      • Fossils
    • Animals
      • Mammals
      • Birds
      • Fish
      • Amphibians
      • Reptiles
      • Invertebrates
      • Pets
      • Conservation
      • Animal facts
    • Climate and Weather
      • Climate change
      • Weather and atmosphere
    • Health
      • Drugs
      • Diseases and Conditions
      • Human Body
      • Mind and Brain
      • Food and Nutrition
      • Wellness
    • History and Humanities
      • Anthropology
      • Archaeology
      • History
      • Economics
      • People
      • Sociology
    • Space & Astronomy
      • The Solar System
      • Sun
      • The Moon
      • Planets
      • Asteroids, meteors & comets
      • Astronomy
      • Astrophysics
      • Cosmology
      • Exoplanets & Alien Life
      • Spaceflight and Exploration
    • Technology
      • Computer Science & IT
      • Engineering
      • Inventions
      • Sustainability
      • Renewable Energy
      • Green Living
    • Culture
    • Resources
  • Videos
  • Reviews
  • About Us
    • About
    • The Team
    • Advertise
    • Contribute
    • Editorial policy
    • Privacy Policy
    • Contact

© 2007-2025 ZME Science - Not exactly rocket science. All Rights Reserved.